High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$39.4M
$39,380,103
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2026-02-27 | $501,386 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2026-02-27 | $931,901 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2026-02-27 | $14,571 | S | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
O'Day Daniel Patrick
• CEO
10b5-1 SellΔOwn -15.8%
2026-02-05
$17,346,000MEGA
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 SellΔOwn -15.8%
|
2026-02-05 | $17,346,000MEGA | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
Other
|
2026-02-05 | $7,633,396Whale | M | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2026-01-28 | $696,725 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2026-01-28 | $702,186 | S | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
O'Day Daniel Patrick
• CEO
10b5-1 SellΔOwn -16.9%
2026-01-23
$15,611,400MEGA
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 SellΔOwn -16.9%
|
2026-01-23 | $15,611,400MEGA | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
Other
|
2026-01-23 | $7,633,396Whale | M | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-11-28 | $404,428 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-11-28 | $861,016 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-10-28 | $240,259 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-10-28 | $953,667 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-09-29 | $896,110 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-09-29 | $220,454 | S | Form 4 |